163 related articles for article (PubMed ID: 38319402)
1. Silencing of METTL3 suppressed ferroptosis of myocardial cells by m6A modification of SLC7A11 in a YTHDF2 manner.
Tang Z; Huang X; Mei H; Zheng Z
J Bioenerg Biomembr; 2024 Apr; 56(2):149-157. PubMed ID: 38319402
[TBL] [Abstract][Full Text] [Related]
2. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
[TBL] [Abstract][Full Text] [Related]
3. N6-methyladenosine writer METTL3 accelerates the sepsis-induced myocardial injury by regulating m6A-dependent ferroptosis.
Shen H; Xie K; Tian Y; Wang X
Apoptosis; 2023 Apr; 28(3-4):514-524. PubMed ID: 36645573
[TBL] [Abstract][Full Text] [Related]
4. YTHDF2 Promotes Cardiac Ferroptosis
Pang P; Si W; Wu H; Ju J; Liu K; Wang C; Jia Y; Diao H; Zeng L; Jiang W; Yang Y; Xiong Y; Kong X; Zhang Z; Zhang F; Song J; Wang N; Yang B; Bian Y
Antioxid Redox Signal; 2023 Nov; ():. PubMed ID: 37548549
[No Abstract] [Full Text] [Related]
5. Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11.
Fan Z; Yang G; Zhang W; Liu Q; Liu G; Liu P; Xu L; Wang J; Yan Z; Han H; Liu R; Shu M
J Cell Mol Med; 2021 Nov; 25(21):10197-10212. PubMed ID: 34609072
[TBL] [Abstract][Full Text] [Related]
6. Methyltransferase-like 3 silenced inhibited the ferroptosis development via regulating the glutathione peroxidase 4 levels in the intracerebral hemorrhage progression.
Zhang L; Wang X; Che W; Yi Y; Zhou S; Feng Y
Bioengineered; 2022 Jun; 13(6):14215-14226. PubMed ID: 35758287
[TBL] [Abstract][Full Text] [Related]
7. METTL3-mediated m6A modification of NORAD inhibits the ferroptosis of vascular smooth muscle cells to attenuate the aortic dissection progression in an YTHDF2-dependent manner.
Liao M; Zou S; Wu J; Bai J; Liu Y; Zhi K; Qu L
Mol Cell Biochem; 2024 Feb; ():. PubMed ID: 38383916
[TBL] [Abstract][Full Text] [Related]
8. METTL3 promotes lung adenocarcinoma tumor growth and inhibits ferroptosis by stabilizing SLC7A11 m
Xu Y; Lv D; Yan C; Su H; Zhang X; Shi Y; Ying K
Cancer Cell Int; 2022 Jan; 22(1):11. PubMed ID: 34996469
[TBL] [Abstract][Full Text] [Related]
9. ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells.
Luo J; Yu H; Yuan Z; Ye T; Hu B
Clin Transl Oncol; 2023 Jul; 25(7):2265-2276. PubMed ID: 36820954
[TBL] [Abstract][Full Text] [Related]
10. Silencing of METTL3 inhibits m6A methylation of NEK7 to suppress pyrolysis in an HT-22 cell-based model of intracerebral hemorrhage.
Hong L; Zhuo T; Jing S
Brain Res; 2024 May; 1831():148828. PubMed ID: 38408556
[TBL] [Abstract][Full Text] [Related]
11. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
12. FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner.
Ji FH; Fu XH; Li GQ; He Q; Qiu XG
Front Endocrinol (Lausanne); 2022; 13():857765. PubMed ID: 35721711
[TBL] [Abstract][Full Text] [Related]
13. METTL3-Mediated N6-Methyladenosine Modification of lncRNA D26496 Suppresses the Proliferation and Migration of Schwann Cells after Sciatic Nerve Injury.
He X; Zhang J; Guo Y; Yang X; Huang Y; Hao D
Mol Neurobiol; 2023 May; 60(5):2413-2425. PubMed ID: 36656457
[TBL] [Abstract][Full Text] [Related]
14. METTL3-regulated m6A modification impairs the decidualization of endometrial stromal cells by regulating YTHDF2-mediated degradation of FOXO1 mRNA in endometriosis-related infertility.
Li X; Jin J; Long X; Weng R; Xiong W; Liang J; Liu J; Sun J; Cai X; Zhang L; Liu Y
Reprod Biol Endocrinol; 2023 Oct; 21(1):99. PubMed ID: 37891533
[TBL] [Abstract][Full Text] [Related]
15. Targeting Ferroptosis as a Novel Approach to Alleviate Aortic Dissection.
Li N; Yi X; He Y; Huo B; Chen Y; Zhang Z; Wang Q; Li Y; Zhong X; Li R; Zhu XH; Fang Z; Wei X; Jiang DS
Int J Biol Sci; 2022; 18(10):4118-4134. PubMed ID: 35844806
[TBL] [Abstract][Full Text] [Related]
16. METTL3-Mediated N6-Methyladenosine Methylation Modifies Foxp3 mRNA Levels and Affects the Treg Cells Proportion in Peripheral Blood of Patients with Asthma.
Fan L; Wu J; Wang H; Chen Q; He X; Wang Q; Yang Z
Ann Clin Lab Sci; 2022 Nov; 52(6):884-894. PubMed ID: 36564065
[TBL] [Abstract][Full Text] [Related]
17. Mettl3-mediated m
Jiang FQ; Liu K; Chen JX; Cao Y; Chen WY; Zhao WL; Song GH; Liang CQ; Zhou YM; Huang HL; Huang RJ; Zhao H; Park KS; Ju Z; Cai D; Qi XF
Elife; 2022 Nov; 11():. PubMed ID: 36399125
[TBL] [Abstract][Full Text] [Related]
18. The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer.
Xu Y; Song M; Hong Z; Chen W; Zhang Q; Zhou J; Yang C; He Z; Yu J; Peng X; Zhu Q; Li S; Ji K; Liu M; Zuo Q
J Exp Clin Cancer Res; 2023 Jan; 42(1):10. PubMed ID: 36609396
[TBL] [Abstract][Full Text] [Related]
19. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
20. Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.
Ni WJ; Zhou H; Lu H; Ma NN; Hou BB; Li W; Kong FX; Yu JT; Hou R; Jin J; Wen JG; Zhang T; Meng XM
Clin Transl Med; 2023 Aug; 13(8):e1359. PubMed ID: 37537731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]